ImmunityBio
IBRX
#2383
Rank
โ‚ฌ6.53 B
Marketcap
6,33ย โ‚ฌ
Share price
2.24%
Change (1 day)
129.06%
Change (1 year)

Revenue for ImmunityBio (IBRX)

Revenue in 2025 (TTM): โ‚ฌ97.59 Million

According to ImmunityBio's latest financial reports the company's current revenue (TTM ) is โ‚ฌ98.17 Million. an increase over the revenue in the year 2024 that were of โ‚ฌ14.16 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunityBio from 2020 to 2025

Annual revenue

Year Revenue Change
2025 โ‚ฌ96.43 M580.6%
2024 โ‚ฌ14.16 M2418.3%
2023 โ‚ฌ0.56 M151.48%
2022 โ‚ฌ0.22 M-72.87%
2021 โ‚ฌ0.82 M67.67%
2020 โ‚ฌ0.49 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA